共 51 条
Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain
被引:157
作者:
Lizée, G
Basha, G
Tiong, J
Julien, JP
Tian, MM
Biron, KE
Jefferies, WA
机构:
[1] Univ British Columbia, Biomed Res Ctr, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada
[4] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada
[5] McGill Univ, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada
基金:
加拿大健康研究院;
关键词:
D O I:
10.1038/ni989
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Dendritic cells (DCs) can present extracellularly derived antigens in the context of major histocompatibility complex (MHC) class I molecules, a process called cross-presentation. Although recognized to be important for priming of T cell responses to many viral, bacterial and tumor antigens, the mechanistic details of this alternative antigen-presentation pathway are poorly understood. We demonstrate here the existence of an endolysosomal compartment in DCs where exogenously derived peptides can be acquired for presentation to T cells, and show that the MHC class I cytoplasmic domain contains a tyrosine-based targeting signal required for routing MHC class I molecules through these compartments. We also report that transgenic mice expressing H-2K(b) with a tyrosine mutation mount inferior H-2K(b)-restricted cytotoxic T lymphocyte responses against two immunodominant viral epitopes, providing evidence of a crucial function for cross-priming in antiviral immunity.
引用
收藏
页码:1065 / 1073
页数:9
相关论文